Evidence map›Paper›PMID 34089411›Full record

ArticleAMB Express2021

Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates.

Masoumeh Kiani, Akram Astani, Gilda Eslami, Mansoor Khaledi, Hamed Afkhami, Soodabeh Rostami, Mohadeseh Zarei, Nahid Rezaei Khozani, Hengameh Zandi

Open access · goldAbstract read
In one paragraph

Article in AMB Express, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Genetic Determinants Linked to MDR/XDR inPathogens (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Risk Factors and Outcomes for Multidrug ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Masoumeh KianiDepartment of Microbiology, Faculty of Medicine, Shahid-Sadoughi University of Medical Sciences, Yazd, Iran.
Akram AstaniDepartment of Microbiology, Faculty of Medicine, Shahid-Sadoughi University of Medical Sciences, Yazd, Iran.
Gilda EslamiDepartment of Parasitology and Mycology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Mansoor KhalediDepartment of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.
Hamed AfkhamiDepartment of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.
Soodabeh RostamiNosocomial infections Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohadeseh ZareiDepartment of Microbiology, Faculty of Medicine, Shahid-Sadoughi University of Medical Sciences, Yazd, Iran.
Nahid Rezaei KhozaniDepartment of Microbiology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Hengameh ZandiDepartment of Microbiology, Faculty of Medicine, Shahid-Sadoughi University of Medical Sciences, Yazd, Iran. h.a.university.ac@gmail.com.
Shahid Sadoughi University of Medical Sciences and Health Services · IRShahed University · IRIsfahan University of Medical Sciences · IRKashan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study was aimed at investigating the prevalence of the mutations upstream of the oprD coding region and its promoters among imipenem-resistant and sensitive Pseudomonas aeruginosa isolated from educational hospitals in Yazd City, Iran. All isolates were identified by the conventional biochemical tests. Then, the antibiotic resistance of these isolates was determined using the disk diffusion method according to the CLSI guidelines. Also, the E.test was performed to determine the minimum inhibitory concentrations (MIC) of imipenem. The mutations of this gene were recognized by the amplification of this region and subsequently sequenced. Sequencing of the genomic region upstream of oprD these regions were done in the 29 clinical strains. Statistical analysis was done by the statistical software SPSS-18. Seventy (77.7%) of isolates had MIC ≥ 16 and were resistant to imipenem. Mutations of the upstream of the oprD gene and its promoters were seen in 25 (86.2%) isolates and 4 isolates had no mutation. One isolate had a base substitution A→Cat nt 25 in the coding region and this isolate had a point mutation leading to an amino acid change at positions 9 (I→L). Our study results indicated that none of the strains had mutation in Shine-Dalgarno and the point mutations were the most common mutations upstream of the oprD coding region among P. aeruginosa isolates. Mutations were observed in imipenem-resistant isolates and it seems this mechanism is effective in resistance of isolates to imipenem and this confirmed that the indiscriminate use of antibiotic should be controlled.

Indexed as

Antimicrobial resistanceImipenemoprDP. aeruginosaPromoterUpstream

Identifiers

PMID34089411
PMCPMC8179858
OpenAlexW3157447196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.